GSK and UK researchers plan to study Shingrix and dementia risk reduction link
GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate…
All articles by Jenna Philpott
Jenna Philpott
Jenna Philpott is a news and features reporter for Pharmaceutical Technology. Jenna holds a BSc in Biochemistry and has interests in rare diseases, gene therapies, and oncology. Contact Jenna
-
-
UKHSA unveils high-risk pathogen list to drive innovation
The UK Health and Security Agency (UKHSA) has released a new watch list of 24 infectious diseases that could pose…
-
Tempero secures $70m to advance addiction treatment candidate
Tempero Bio has raised $70m in Series B financing to advance its lead candidate TMP-301 through two clinical trials for…
-
Augustine secures $85m to advance Charcot-Marie-Tooth candidate
Belgium-based biotech Augustine Therapeutics has raised €78m ($85m) in funding to support the development of its lead candidate as it…
-
J&J boosts US operations with $55bn investment
Johnson & Johnson Innovative Medicine (J&J) is significantly expanding its US footprint with a $55bn investment over the next four…
-
Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug
Alnylam Pharmaceutical’s has secured US Food and Drug Administration (FDA) approval for Amvuttra (vutrisiran), expanding its use to treat transthyretin…
-
Investigating key strategies for optimising clinical trial supply chains in 2025
As the clinical trial landscape evolves with a growing demand for efficiency, flexibility, and innovation in 2025, experts will gather…
-
AstraZeneca director says AI must be a “thought partner” in drug discovery
Artificial intelligence (AI) is transforming drug discovery, but its implementation must be thoughtful and strategic, according to Krishna Bulusu, senior…
-
MeiraGTx and Hologen launch AI-backed gene therapy venture
MeiraGTx has struck a deal with Hologen Limited, an artificial intelligence (AI) company specialising in multimodal generative AI models, to…
-
Gedeon Richter’s once-daily endometriosis pill approved for NHS use
The UK’s National Institute for Health and Care (NICE) has approved Gedeon Richter’s Ryeqo (relugolix–estradiol–norethisterone), a once-daily oral treatment for…